News
Cardiologist Dr Alok Chopra emphasises the importance of testing insulin levels as normal blood sugar can hide insulin ...
Peptides have emerged as a fascinating area of scientific inquiry due to their potential to modulate various physiological ...
The best sheet masks are among the most underrated products in skin care. For the casual consumer, navigating the world of ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 1, ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Postbiotics are a new category in the functional ingredient space. They do away with the need to add probiotics by being the ...
For those who missed out on Amazon's massive Prime Day sale last week and are still looking to bag a beauty bargain, Boots has just launched a massive sale on No7 products. The high street retailer is ...
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.
Researchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of ...
Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.
A new pilot study published in the BMC Nephrology revealed that while brain natriuretic peptide (BNP) levels were associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results